ELIZABETH BROWN: Open Payments
NPI 1831604917 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,293 in 25 payments from 13 companies in 2025. Trend: 2023 $1,028 · 2024 $965 · 2025 $1,293
Food & beverage: $1,293
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 2 | $179 |
| Novartis Pharmaceuticals Corporation | 7 | $165 |
| AstraZeneca Pharmaceuticals LP | 3 | $158 |
| Ancora Heart, Inc. | 2 | $158 |
| Inspire Medical Systems, Inc. | 1 | $154 |
| BridgeBio Pharma, Inc. | 2 | $147 |
| Itamar Medical Inc | 1 | $97 |
| ABIOMED | 2 | $84 |
| E.R. Squibb & Sons, L.L.C. | 1 | $58 |
| Lexicon Pharmaceuticals, Inc. | 1 | $31 |
Products named: Barostim Neo System, AccuCinch, INSPIRE, Attruby, LEQVIO, WAINUA, WatchPATONE, CAMZYOS.
Industry payments across TX — which companies pay providers there.
